BlackRock Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.32M | Buy |
45,695
+9,259
| +25% | +$267K | ﹤0.01% | 2503 |
|
|
2016
Q3 | $1.16M | Buy |
36,436
+1,067
| +3% | +$33.9K | ﹤0.01% | 2555 |
|
|
2016
Q2 | $1.15M | Sell |
35,369
-258,595
| -88% | -$8.39M | ﹤0.01% | 2521 |
|
|
2016
Q1 | $8.22M | Buy |
293,964
+12,124
| +4% | +$339K | 0.01% | 1044 |
|
|
2015
Q4 | $10M | Buy |
281,840
+1,515
| +0.5% | +$54K | 0.01% | 937 |
|
|
2015
Q3 | $9.27M | Sell |
280,325
-3,357
| -1% | -$111K | 0.01% | 972 |
|
|
2015
Q2 | $11.9M | Buy |
283,682
+63,974
| +29% | +$2.68M | 0.01% | 892 |
|
|
2015
Q1 | $7.16M | Buy |
219,708
+2,985
| +1% | +$97.3K | 0.01% | 1151 |
|
|
2014
Q4 | $6.88M | Sell |
216,723
-1,783
| -0.8% | -$56.6K | 0.01% | 1165 |
|
|
2014
Q3 | $5.41M | Sell |
218,506
-28,144
| -11% | -$697K | 0.01% | 1283 |
|
|
2014
Q2 | $5.57M | Buy |
246,650
+30,840
| +14% | +$697K | 0.01% | 1311 |
|
|
2014
Q1 | $5.25M | Buy |
215,810
+20,727
| +11% | +$504K | 0.01% | 1325 |
|
|
2013
Q4 | $4.88M | Sell |
195,083
-4,992
| -2% | -$125K | 0.01% | 1356 |
|
|
2013
Q3 | $5.5M | Buy |
200,075
+11,589
| +6% | +$318K | 0.01% | 1220 |
|
|
2013
Q2 | $3.42M | Buy |
+188,486
| New | +$3.42M | 0.01% | 1465 |
|